| Association between mood disorders and risk of COVID-19 infection, hospitalization, and death: a systematic review and meta-analysis F Ceban, D Nogo, IP Carvalho, Y Lee, F Nasri, J Xiong, LMW Lui, ... JAMA psychiatry 78 (10), 1079-1091, 2021 | 190 | 2021 |
| The effect of intravenous, intranasal, and oral ketamine in mood disorders: a meta-analysis RS McIntyre, IP Carvalho, LMW Lui, A Majeed, PS Masand, H Gill, ... Journal of affective disorders 276, 576-584, 2020 | 153 | 2020 |
| The acute antisuicidal effects of single-dose intravenous ketamine and intranasal esketamine in individuals with major depression and bipolar disorders: a systematic review and … J Xiong, O Lipsitz, D Chen-Li, JD Rosenblat, NB Rodrigues, I Carvalho, ... Journal of psychiatric research 134, 57-68, 2021 | 93 | 2021 |
| The effectiveness of repeated intravenous ketamine on depressive symptoms, suicidal ideation and functional disability in adults with major depressive disorder and bipolar … RS McIntyre, NB Rodrigues, Y Lee, O Lipsitz, M Subramaniapillai, H Gill, ... Journal of affective disorders 274, 903-910, 2020 | 78 | 2020 |
| Management of cognitive impairment in bipolar disorder: a systematic review of randomized controlled trials JK Tamura, IP Carvalho, LMW Leanna, JN Feng, JD Rosenblat, R Mansur, ... CNS spectrums 27 (4), 399-420, 2022 | 19 | 2022 |
| Association between mood disorders and risk of COVID-19 infection, hospitalization, and death: a systematic review and meta-analysis. JAMA Psychiatry. 2021;[Epub ahead of print] F Ceban, D Nogo, IP Carvalho, Y Lee, F Nasri, J Xiong, LMW Lui, ... | 15 | 1818 |
